Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tempest Therapeutics (TPST)
NASDAQ:TPST
RESEARCH TOOLSreports
Tempest Therapeutics (TPST) Stock Price & Analysis
791 Followers
TPST Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.17 - $9.77
Previous Close$3.71
Volume677.97K
Average Volume (3M)684.00K
Market Cap
$82.33M
Enterprise Value$92.24M
Total Cash (Recent Filing)$11.10M
Total Debt (Recent Filing)$21.01M
Price to Earnings (P/E)-1.9
Beta2.11
Next Earnings
May 09, 2024EPS Estimate
-$0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.92
Shares Outstanding22,192,026
10 Day Avg. Volume669,672
30 Day Avg. Volume684,003
Standard Deviation1.64
R-Squared0.00311
Alpha0.16
Financial Highlights & Ratios
Price to Book (P/B)-69.19
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.47
Forecast
1Y Price Target
$20.75Price Target Upside430.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Tempest Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
TPST FAQ
What was Tempest Therapeutics’s price range in the past 12 months?
Tempest Therapeutics lowest stock price was $0.17 and its highest was $9.77 in the past 12 months.
What is Tempest Therapeutics’s market cap?
Currently, no data Available
When is Tempest Therapeutics’s upcoming earnings report date?
Tempest Therapeutics’s upcoming earnings report date is May 09, 2024 which is in 19 days.
How were Tempest Therapeutics’s earnings last quarter?
Tempest Therapeutics released its earnings results on Mar 19, 2024. The company reported -$0.38 earnings per share for the quarter, beating the consensus estimate of -$0.387 by $0.007.
Is Tempest Therapeutics overvalued?
According to Wall Street analysts Tempest Therapeutics’s price is currently Undervalued.
Does Tempest Therapeutics pay dividends?
Tempest Therapeutics does not currently pay dividends.
What is Tempest Therapeutics’s EPS estimate?
Tempest Therapeutics’s EPS estimate is -$0.4.
How many shares outstanding does Tempest Therapeutics have?
Tempest Therapeutics has 22,192,026 shares outstanding.
What happened to Tempest Therapeutics’s price movement after its last earnings report?
Tempest Therapeutics reported an EPS of -$0.38 in its last earnings report, beating expectations of -$0.387. Following the earnings report the stock price went up 0.535%.
Which hedge fund is a major shareholder of Tempest Therapeutics?
Among the largest hedge funds holding Tempest Therapeutics’s share is GMT Capital Corp. It holds Tempest Therapeutics’s shares valued at N/A.
---
Tempest Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.75 (430.69% Upside)
$20.75 (430.69% Upside)
Blogger Sentiment
Bullish
TPST Sentiment 90%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 9.1%
Last 30 Days ▲ 17.6%
Last 30 Days ▲ 17.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
170.40%
12-Months-Change
Fundamentals
Return on Equity
-131.42%
Trailing 12-Months
Asset Growth
11.96%
Trailing 12-Months
Company Description
Tempest Therapeutics
Tempest Therapeutics is a clinical-stage biotechnology company focused on developing small-molecule therapeutics to treat cancer.
---
TPST Stock 12 Months Forecast
Average Price Target
$20.75
▲(430.69% Upside)
Technical Analysis
Best Analysts Covering TPST
1 Year
1 Year Success Rate
10/10 ratings generated profit
1 Year Average Return
+194.32%
reiterated a buy rating last month
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +194.32% per trade.
---